Bahceci Health Group

What Bahceci Health Group does

Bahceci Health Group (Bahçeci Sağlık Hizmetleri A.Ş.) is a Turkish fertility and reproductive-medicine operator founded in 1996 and headquartered in Şişli, Istanbul. The group runs 10 wholly-owned treatment centers across five countries — six in Turkey (Istanbul x2, Ankara, İzmir, Bursa, Diyarbakır) and one each in Bulgaria (Sofia), Bosnia and Herzegovina (Sarajevo), and Kosovo (Pristina) — and actively attracts medical tourists from 105 countries through multilingual coordination teams and a 12-language website.

The service portfolio centers on in vitro fertilization and reproductive genetics, with advanced laboratory capabilities including AI-enhanced preimplantation genetic testing (Smart PGT), next-generation sequencing, mitochondrial scoring (MitoSkor), time-lapse incubation (Embriyoskop), high-magnification sperm injection (IMSI), Micro-TESE for male-factor azoospermia, PRP for ovarian rejuvenation, and the proprietary Bahceci MAX digital sample-security system. Success rates are claimed to exceed European averages, particularly in difficult cases, supported by weekly multidisciplinary review among 40+ doctors across the network.

Revenue is generated primarily through per-cycle IVF treatment fees (professional services model) with selective SGK (Turkish Social Security Institution) reimbursement at the Ankara and Bursa centers. The company reports 130,000+ cumulative healthy births and approximately 2.5 babies per hour (~21,900 per year). Following a 2025 strategic partnership with FutureLife Group, Bahceci now operates within a 16-country, 60+ center reproductive-health network, alongside a newly signed scientific collaboration with the University of Oxford.

Name

Bahceci Health Group

Legal name

Bahçeci Sağlık Hizmetleri A.Ş.

Website

https://bahceci.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Bahceci Health Group is a Turkish fertility and IVF operator founded in 1996, running 10 centers across five countries and serving patients from 105 countries with AI-enhanced reproductive genetics and a FutureLife Group partnership.

Ownership category

akta.pro rank

Product category

Reproductive Medicine & Fertility Services

NAICS

Family Planning Centers (621410), Medical Laboratories (621511)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• Infertility treatment
• In vitro fertilization
• Reproductive medicine
• Fertility preservation
• Embryology services

Headquarters

HQ city

Sisli

Offices9 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IVF and Infertility Treatment Services: Revenue generated from providing IVF treatments, infertility diagnostics, fertility medications management, and assisted reproductive technology procedures. Services include egg collection, embryo transfer, sperm freezing, embryo freezing, and genetic testing. Treatment duration is typically 15-18 days with 6-7 center visits.
2. SGK (Social Security Institution) Government Coverage: Government health insurance reimbursement for eligible patients at Ankara and Bursa centers. Patients need SSI committee approval, meet age criteria (23-40 years for women), 3 years marriage requirement, and 900 premium days.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Bahceci Health Group is a reproductive medicine network that delivers in vitro fertilization (IVF) and comprehensive infertility diagnosis and treatment services through 10 treatment centers across 5 countries (Turkey, Bosnia and Herzegovina, Bulgaria, Kosovo, and Iraq). Its portfolio spans IVF, ICSI/IMSI, Micro TESE, PGT/NGS genetic testing, egg and sperm freezing, gynecological care, pregnancy follow-up, and assisted reproductive technologies supported by an ESHRE-certified embryology laboratory and AI-augmented embryo selection tools.

Product overview

Bahçeci Health Group operates as a comprehensive fertility healthcare network offering a unified platform of reproductive health services. The core offering centers on Tüp Bebek (IVF) treatments supported by specialized services for male and female infertility, gynecology, and pregnancy follow-up care. The portfolio includes diagnostic and surgical services such as endoscopic surgery, hysteroscopy, andMicro-TESE, alongside advanced laboratory techniques including IMSI for sperm selection, PGT/NGS for genetic screening, and the AI-enhanced Smart PGT system. Additional modules encompass egg and sperm freezing, PRP treatment methods, psychological counseling, and the pregnancy school educational program. Digital infrastructure includes the e-Sonuç patient portal and Bahçeci MAX electronic security system for sample protection. The group maintains international presence across Turkey, Bosnia, Bulgaria, Kosovo, and Iraq with 10 centers.

Differentiator

Problem solved

Functional benefit

Brands

• Bahçeci MAX: E-security and digital verification system for sperm, egg, and embryo protection.
• e-Sonuç

Products and services

• Tüp Bebek (IVF - In Vitro Fertilization) Core in vitro fertilization treatment service for couples with infertility, involving egg collection, laboratory fertilization, embryo development and transfer.
• Kısırlık Tedavileri (Infertility Treatments) Comprehensive diagnosis and treatment of various fertility conditions for couples, including unexplained infertility and recurrent IVF failures.
• Erkek İnfertilitesi (Male Infertility) Male infertility diagnosis and treatment including azoospermia, varicocele, urology consultations, and sperm freezing.
• Jinekoloji (Gynecology)

Quantifiable outcome

• 130,000+ healthy babies delivered through Bahceci treatments
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Two partnerships are on record, tiered core.

• FutureLife GroupcoreStrategic or Co-development PartnerPartnership with FutureLife Group, one of the world's largest health groups in IVF and genetics. Through this alliance, Bahçeci operates within a network of 16 countries, 60+ centers, and 2,100+ experts. The partnership strengthens Bahceci's global reach and positions it as a key player in the international reproductive health ecosystem.
• University of OxfordcoreStrategic or Co-development PartnerScientific research collaboration with University of Oxford in reproductive genetics, embryology, and advanced IVF technologies. This collaboration provides access to cutting-edge academic research and validates Bahceci's scientific approach through association with a world-leading institution.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Regional players

• First IVF: Israel-based fertility clinic chain operating multiple sites with a focus on PGT and complex cases. Comparable to Bahceci in technology-forward IVF offering and difficulty-case specialization, but regional in geographic focus to the Middle East.
• Medfem Fertility Clinic: South African fertility clinic offering IVF, ICSI, PGT, and surrogacy services across sub-Saharan Africa. Comparable to Bahceci in regional reproductive medicine leadership, but operating in a different geographic market with some cross-border patient flow.

Direct peers

• Bourn Hall Clinic: Historic UK fertility clinic group (founded as the world's first IVF clinic) operating multiple UK sites offering IVF, ICSI, and PGT. Comparable to Bahceci in established multi-site IVF clinic model with international brand recognition in reproductive medicine.
• New Hope Fertility Center: US-based fertility clinic with international locations in Mexico and elsewhere, known for proprietary Natural Cycle and Mini-IVF protocols. Directly comparable to Bahceci in cross-border IVF service offering and emphasis on protocol differentiation.
• Genea: Australian-headquartered fertility group operating clinics and embryology labs globally with proprietary technology (e.g., Geri time-lapse incubators). Comparable to Bahceci in scale, multi-country clinic model, and emphasis on proprietary lab technology and outcomes-driven positioning.
• IVI-RMA (Eugin Group): Global IVF and reproductive medicine group headquartered in Spain with clinics across Europe, the Americas, and Asia. Directly comparable to Bahceci as one of the world's largest multi-country IVF chains serving cross-border fertility patients with similar technology stacks (PGT, time-lapse, AI embryo selection).
• CARE Fertility: UK-based fertility clinic group offering IVF, ICSI, PGT, and genetic screening with multiple sites across the UK. Comparable to Bahceci as a multi-site reproductive medicine chain with strong R&D focus and difficulty-case specialization.

Broad incumbents

• Inception Fertility: US fertility clinic network backed by PE (InTandem Capital) operating multiple brands and clinics across the US. Comparable to Bahceci in PE-aligned, multi-site IVF operating model with international expansion ambitions.
• Monash IVF: Publicly listed Australian IVF and ultrasound diagnostics group with clinics in Australia, Malaysia, and Indonesia. Comparable to Bahceci in core IVF service offering with international clinic footprint, though broader incumbent given its diagnostics diversification.
• Virtus Health: Australia-listed fertility and specialist day hospital group with clinics in Australia, Ireland, and the UK. Broader incumbent versus Bahceci given public-market scale and diversified specialist services, but operates the same multi-site reproductive medicine model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/bahcecifertility
• Instagraminstagram.com/bahcecisaglik
• Xx.com/bahcecisaglik
• LinkedInlinkedin.com/company/bahcecisaglik

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bahceci Health Group